Total Payments
$1,734
2023 Payments
$355.60
Companies
29
Transactions
96
Medicare Patients
1,154
Medicare Billing
$171,016
Payment Breakdown by Category
Food & Beverage$1,710 (98.6%)
Education$23.92 (1.4%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,710 | 94 | 98.6% |
| Education | $23.92 | 2 | 1.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $214.64 | 14 | $0 (2022) |
| Veran Medical Technologies, Inc. | $198.12 | 3 | $0 (2019) |
| Novartis Pharmaceuticals Corporation | $165.60 | 10 | $0 (2023) |
| Merck Sharp & Dohme LLC | $145.31 | 8 | $0 (2022) |
| Janssen Biotech, Inc. | $87.73 | 5 | $0 (2023) |
| Novocure Inc. | $82.36 | 1 | $0 (2017) |
| PFIZER INC. | $81.91 | 7 | $0 (2023) |
| GENZYME CORPORATION | $74.25 | 4 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $74.16 | 6 | $0 (2021) |
| Gilead Sciences, Inc. | $73.46 | 5 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $355.60 | 19 | GENZYME CORPORATION ($47.62) |
| 2022 | $339.03 | 20 | Amgen Inc. ($50.85) |
| 2021 | $267.86 | 18 | Novartis Pharmaceuticals Corporation ($48.91) |
| 2020 | $11.91 | 1 | Astellas Pharma US Inc ($11.91) |
| 2019 | $183.41 | 11 | Amgen Inc. ($50.61) |
| 2018 | $201.95 | 8 | Veran Medical Technologies, Inc. ($116.06) |
| 2017 | $374.46 | 19 | Novocure Inc. ($82.36) |
All Payment Transactions
96 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/08/2023 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $15.59 | General |
| 08/25/2023 | GENZYME CORPORATION | JEVTANA (Drug) | Food and Beverage | In-kind items and services | $34.63 | General |
| Category: Oncology | ||||||
| 08/18/2023 | GENZYME CORPORATION | SARCLISA (Biological) | Food and Beverage | In-kind items and services | $12.99 | General |
| Category: Oncology | ||||||
| 08/11/2023 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $13.31 | General |
| Category: ONCOLOGY | ||||||
| 07/28/2023 | Stemline Therapeutics Inc. | Orserdu (Drug) | Food and Beverage | In-kind items and services | $18.64 | General |
| Category: Oncology | ||||||
| 07/07/2023 | Novartis Pharmaceuticals Corporation | TASIGNA (Drug), SCEMBLIX | Food and Beverage | In-kind items and services | $18.35 | General |
| Category: Oncology | ||||||
| 06/10/2023 | Janssen Biotech, Inc. | — | Food and Beverage | In-kind items and services | $20.53 | General |
| 06/02/2023 | Novartis Pharmaceuticals Corporation | KISQALI (Drug), PIQRAY | Food and Beverage | In-kind items and services | $24.08 | General |
| Category: Oncology | ||||||
| 05/26/2023 | Takeda Pharmaceuticals U.S.A., Inc. | NINLARO (Drug) | Food and Beverage | In-kind items and services | $29.75 | General |
| Category: ONCOLOGY | ||||||
| 05/05/2023 | Mirati Therapeutics, Inc. | KRAZATI (Drug) | Food and Beverage | In-kind items and services | $12.97 | General |
| Category: ONCOLOGY | ||||||
| 04/29/2023 | Gilead Sciences, Inc. | Trodelvy (Drug) | Food and Beverage | In-kind items and services | $13.10 | General |
| Category: ONC | ||||||
| 04/07/2023 | Rigel Pharmaceuticals, Inc. | Rezlidhia (Drug), Tavalisse | Food and Beverage | Cash or cash equivalent | $13.77 | General |
| Category: Acute Myeloid Leukemia | ||||||
| 03/31/2023 | Janssen Biotech, Inc. | DARZALEX (Biological), TECVAYLI | Food and Beverage | In-kind items and services | $18.12 | General |
| Category: Oncology | ||||||
| 03/24/2023 | Myriad Genetic Laboratories, Inc. | PRECISETUMOR (Device) | Food and Beverage | In-kind items and services | $19.39 | General |
| Category: ONCOLOGY | ||||||
| 02/25/2023 | Gilead Sciences, Inc. | Trodelvy (Drug) | Food and Beverage | In-kind items and services | $16.44 | General |
| Category: ONC | ||||||
| 02/10/2023 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $13.04 | General |
| 01/27/2023 | GlaxoSmithKline, LLC. | — | Food and Beverage | In-kind items and services | $19.14 | General |
| 01/13/2023 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $26.11 | General |
| Category: ONCOLOGY | ||||||
| 01/06/2023 | Genentech USA, Inc. | Venclexta (Biological) | Food and Beverage | In-kind items and services | $15.65 | General |
| Category: BioOncology | ||||||
| 11/19/2022 | Exelixis Inc. | Cabometyx (Drug) | Food and Beverage | Cash or cash equivalent | $19.20 | General |
| Category: Oncology | ||||||
| 11/05/2022 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $18.65 | General |
| 10/27/2022 | AstraZeneca Pharmaceuticals LP | TAGRISSO (Drug) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: Oncology | ||||||
| 09/16/2022 | Gilead Sciences, Inc. | Trodelvy (Drug) | Food and Beverage | In-kind items and services | $16.41 | General |
| Category: ONC | ||||||
| 09/02/2022 | Amgen Inc. | Kyprolis (Drug) | Food and Beverage | In-kind items and services | $20.13 | General |
| Category: Oncology | ||||||
| 08/19/2022 | Amgen Inc. | LUMAKRAS (Drug) | Food and Beverage | In-kind items and services | $16.53 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 267 | 597 | $138,499 | $41,032 |
| 2022 | 5 | 263 | 558 | $95,298 | $37,470 |
| 2021 | 6 | 329 | 739 | $130,818 | $51,963 |
| 2020 | 5 | 295 | 695 | $123,488 | $40,552 |
Total Patients
1,154
Total Services
2,589
Medicare Billing
$171,016
Procedure Codes
22
All Medicare Procedures & Services
22 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 181 | 463 | $111,523 | $32,804 | 29.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 33 | 45 | $7,023 | $2,256 | 32.1% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 14 | 35 | $7,167 | $2,096 | 29.2% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 15 | 16 | $5,358 | $1,623 | 30.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 12 | 12 | $4,048 | $1,244 | 30.7% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 12 | 26 | $3,380 | $1,009 | 29.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 187 | 447 | $78,225 | $31,316 | 40.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 20 | 20 | $5,780 | $2,106 | 36.4% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 15 | 33 | $5,379 | $1,816 | 33.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 26 | 30 | $3,450 | $1,455 | 42.2% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 15 | 28 | $2,464 | $776.08 | 31.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 209 | 561 | $98,175 | $40,376 | 41.1% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 26 | 62 | $10,106 | $3,425 | 33.9% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 31 | 31 | $9,013 | $3,251 | 36.1% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 21 | 25 | $7,650 | $2,655 | 34.7% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 22 | 38 | $3,344 | $1,141 | 34.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 20 | 22 | $2,530 | $1,115 | 44.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 204 | 560 | $98,000 | $31,878 | 32.5% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 27 | 66 | $10,758 | $3,782 | 35.2% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 20 | 21 | $6,426 | $2,288 | 35.6% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 16 | 16 | $4,624 | $1,647 | 35.6% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 28 | 32 | $3,680 | $957.06 | 26.0% |
About Dr. Brian Gaupp, M.D
Dr. Brian Gaupp, M.D is a Hematology & Oncology healthcare provider based in Thomasville, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/17/2005. The National Provider Identifier (NPI) number assigned to this provider is 1649265430.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Brian Gaupp, M.D has received a total of $1,734 in payments from pharmaceutical and medical device companies, with $355.60 received in 2023. These payments were reported across 96 transactions from 29 companies. The most common payment nature is "Food and Beverage" ($1,710).
As a Medicare-enrolled provider, Gaupp has provided services to 1,154 Medicare beneficiaries, totaling 2,589 services with total Medicare billing of $171,016. Data is available for 4 years (2020–2023), covering 22 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology & Oncology
- Location Thomasville, GA
- Active Since 09/17/2005
- Last Updated 09/17/2020
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1649265430
Products in Payments
- Spin (Device) $198.12
- KEYTRUDA (Biological) $145.31
- Neulasta (Biological) $92.70
- Optune (Device) $82.36
- KISQALI (Drug) $76.72
- LIBTAYO (Biological) $58.25
- ELIQUIS (Drug) $51.50
- NINLARO (Drug) $50.65
- JEVTANA (Drug) $47.86
- Trodelvy (Drug) $45.95
- LUMAKRAS (Drug) $45.34
- EMPLICITI (Biological) $33.36
- DARZALEX (Biological) $33.20
- MEKINIST (Drug) $29.80
- VOTRIENT (Drug) $26.08
- BOSULIF (Drug) $23.08
- ULTOMIRIS (Drug) $22.50
- RYBREVANT (Drug) $20.73
- Kyprolis (Drug) $20.13
- PRECISETUMOR (Device) $19.39
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.